Amgen Inc: Why You Shouldn't Count Chickens Before They Hatch

<p><span style="font-family: Calibri, Arial, Helvetica, sans-serif; font-size: 16px;">Amgen has shelved its once-promising psoriasis drug. Motley Fool's Michael Douglass and Todd Campbell help investors understand the impact.</span></p>